NKTR Financials 07/22/2014 01:15:43
Nektar Therapeutics
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 148,921 81,191 71,480 159,039
Cost of Revenue 38,509 30,428 21,891 25,667
Gross Profit 110,412 50,763 49,589 133,372
Operating Expenses
Research and Development 190,010 148,675 126,766 108,065
Sales, General and Admin. 40,532 41,614 46,760 40,986
Non-Recurring Items - 1,675 - 12,576
Other - - - -
Operating Income (120,130) (141,201) (123,937) (28,255)
Income From Continuing Operations
Add'l Income/Expense Items 1,124 3,298 1,200 2,372
Earnings Before Interest and Tax (119,006) (137,903) (122,737) (25,883)
Interest Expense 40,762 33,546 10,223 11,174
Earnings Before Tax (159,768) (171,449) (132,960) (37,057)
Income Tax 2,245 406 1,018 881
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (162,013) (171,855) (133,978) (37,938)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (162,013) (171,855) (133,978) (37,938)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (162,013) (171,855) (133,978) (37,938)
Nektar Therapeutics
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 148,921 81,191 71,480 159,039
Cost of Revenue 38,509 30,428 21,891 25,667
Gross Profit 110,412 50,763 49,589 133,372
Operating Expenses
Research and Development 190,010 148,675 126,766 108,065
Sales, General and Admin. 40,532 41,614 46,760 40,986
Non-Recurring Items - 1,675 - 12,576
Other - - - -
Operating Income (120,130) (141,201) (123,937) (28,255)
Income From Continuing Operations
Add'l Income/Expense Items 1,124 3,298 1,200 2,372
Earnings Before Interest and Tax (119,006) (137,903) (122,737) (25,883)
Interest Expense 40,762 33,546 10,223 11,174
Earnings Before Tax (159,768) (171,449) (132,960) (37,057)
Income Tax 2,245 406 1,018 881
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (162,013) (171,855) (133,978) (37,938)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (162,013) (171,855) (133,978) (37,938)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (162,013) (171,855) (133,978) (37,938)
